Keeping sleeping glioma cells asleep
Original title: Shared molecular regulation of quiescence in neural and glioma stem cells reveals therapeutic vulnerabilities.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was only done with cells in the lab.
The short version
Lab work points to a way to stop hidden tumor cells from waking up.
What was studied. Researchers used glioma: A tumor that starts in the glial cells. Those are the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4. The grade says how the tumor is expected to act. See the glossary cells grown in the lab from patients' tumors. They compared those cells to healthy brain stem cells, then screened more than 3,000 compounds for ones that keep cells resting.
What they found. Some glioma: A tumor that starts in the glial cells. Those are the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4. The grade says how the tumor is expected to act. See the glossary cells drop into a resting state. In that state, chemo and radiation do not kill them, and later they wake up and the tumor grows back. The team found resting glioma cells follow many of the same steps as healthy brain stem cells when they wake up. Three groups of drugs pushed glioma cells toward rest in the lab.
What this means, and what it doesn't
What it could mean: Nothing about care changes today. It offers a new idea to test: hold the cells asleep instead of only trying to kill them. It also gives researchers an easier way to look for such drugs.
What it doesn't mean: This was done with cells in the lab, not in people. No patient was treated. It does not mean a new drug is close. It is not a cure, and it is a long way from everyday care.
Source: PubMed, November 5, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.